Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial von D’Agnolo, Hedwig M.A, Kievit, Wietske, Takkenberg, R. Bart, Riaño, Ioana, Bujanda, Luis, Neijenhuis, Myrte K, Brunenberg, Ellen J.L, Beuers, Ulrich, Banales, Jesus M, Drenth, Joost P.H

Volltext

The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease von D'Agnolo, Hedwig M.A., Casteleijn, Niek F., Gevers, Tom J.G., de Fijter, Hans, van Gastel, Maartje D.A., Messchendorp, Annemarie L., Peters, Dorien J.M., Salih, Mahdi, Soonawala, Darius, Spithoven, Edwin M., Visser, Folkert W., Wetzels, Jack F.M., Zietse, Robert, Gansevoort, Ron T., Drenth, Joost P.H.

Volltext

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease von van Aerts, Rene M.M., Kievit, Wietske, D’Agnolo, Hedwig M.A., Blijdorp, Charles J., Casteleijn, Niek F., Dekker, Shosha E.I., de Fijter, Johan W., van Gastel, Maatje, Gevers, Tom J., van de Laarschot, Liyanne F.M., Lantinga, Marten A., Losekoot, Monique, Meijer, Esther, Messchendorp, A. Lianne, Neijenhuis, Myrte K., Pena, Michelle J., Peters, Dorien J.M., Salih, Mahdi, Soonawala, Darius, Spithoven, Edwin M., Visser, Folkert W., Wetzels, Jack F., Zietse, Robert, Gansevoort, Ron T., Drenth, Joost P.H.

Volltext

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial von Meijer, Esther, Visser, Folkert W, van Aerts, Rene M. M, Blijdorp, Charles J, Casteleijn, Niek F, D‘Agnolo, Hedwig M. A, Dekker, Shosha E. I, Drenth, Joost P. H, de Fijter, Johan W, van Gastel, Maatje D. A, Gevers, Tom J, Lantinga, Marten A, Losekoot, Monique, Messchendorp, A. Lianne, Neijenhuis, Myrte K, Pena, Michelle J, Peters, Dorien J. M, Salih, Mahdi, Soonawala, Darius, Spithoven, Edwin M, Wetzels, Jack F, Zietse, Robert, Gansevoort, Ron T

Volltext

Risk factors for progressive polycystic liver disease: where do we stand? von D'Agnolo, Hedwig M A, Drenth, Joost P H

Volltext

Center is an important indicator for choice of invasive therapy in polycystic liver disease von D'Agnolo, Hedwig M. A., Kievit, Wietske, Munster, Kim N., Laan, Jouke J. H., Nevens, Frederik, Drenth, Joost P. H.

Volltext

Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes von de Jonge, Charlotte, Rensen, Sander S., D’Agnolo, Hedwig M. A., Bouvy, Nicole D., Buurman, Wim A., Greve, Jan Willem M.

Volltext

Center is an important indicator for choice of invasive therapy in polycystic liver disease von D'Agnolo, Hedwig M.A, Kievit, Wietske, van Munster, Kim N, Vd Laan, Jouke J.H, Nevens, Frederik, Drenth, Joost P.H

Volltext

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicente... von Lantinga, Marten A., D’Agnolo, Hedwig M. A., Casteleijn, Niek F., de Fijter, Johan W., Meijer, Esther, Messchendorp, Annemarie L., Peters, Dorien J. M., Salih, Mahdi, Spithoven, Edwin M., Soonawala, Darius, Visser, Folkert W., Wetzels, Jack F. M., Zietse, Robert, Drenth, Joost P. H., Gansevoort, Ron T.

Volltext

Creating an effective clinical registry for rare diseases von D’Agnolo, Hedwig MA, Kievit, Wietske, Andrade, Raul J, Karlsen, Tom Hemming, Wedemeyer, Heiner, Drenth, Joost PH

Volltext